aware offers regular blood tests with lab draws and delivers personalised health reports to users via its app, typically within 24 hours. The company is launching a private beta in Berlin where customers can book blood draws, receive results, and opt to retest every 3 to 6 months. Its core product combines frequent biomarker data with a data-driven app to give individuals actionable insights and encourage preventive care. Longer-term, aware aims to build Europe’s largest health database for personalised medicine to contribute to medical research and inform new treatments. The team includes former EyeEm founders Florian Meissner and Ramzi Rizk alongside Ferdinand Schmidt-Thomé, who oversees lab relationships and partnerships. Financially, aware has secured a $15 million seed round to support product rollout and the company’s ambitions in digitising regular medical checkups.

Total raised

$15M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2022